Acrivon Therapeutics, Inc.
ACRV
$2.06
-$0.04-1.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -34.54% | -34.68% | -33.93% | -31.05% | -23.88% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 55.11% | -12.35% | -13.31% | -27.69% | -45.69% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.90% | -34.43% | -33.69% | -31.02% | -24.10% |
|
|
|||||
| Total Current Assets | -33.90% | -34.43% | -33.69% | -31.02% | -24.10% |
| Net Property, Plant & Equipment | -23.38% | -13.46% | -7.59% | -5.74% | 9.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.65% | -7.64% | 0.60% | 0.33% | 107.87% |
| Total Assets | -37.51% | -38.85% | -34.02% | -32.32% | -31.23% |
|
|
|||||
| Total Accounts Payable | -25.97% | -68.52% | 200.40% | -33.86% | -7.77% |
| Total Accrued Expenses | -10.46% | 4.01% | -21.61% | 4.03% | 20.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.13% | 4.25% | 10.88% | 13.85% | 17.38% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 99.65% |
| Total Other Current Liabilities | -- | -- | -- | -- | 99.65% |
| Total Current Liabilities | -14.77% | -18.42% | -9.00% | 0.49% | 19.03% |
|
|
|||||
| Total Current Liabilities | -14.77% | -18.42% | -9.00% | 0.49% | 19.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -53.66% | -47.57% | -40.61% | -39.29% | -34.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -20.06% | -22.82% | -13.14% | -6.16% | 7.01% |
|
|
|||||
| Common Stock & APIC | 4.73% | 3.36% | 3.74% | 3.82% | 3.48% |
| Retained Earnings | -31.23% | -35.66% | -39.55% | -46.94% | -56.66% |
| Treasury Stock & Other | -131.13% | -98.59% | -75.17% | -85.68% | 657.89% |
| Total Common Equity | -39.41% | -40.45% | -36.35% | -34.68% | -33.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -39.41% | -40.45% | -36.35% | -34.68% | -33.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -39.41% | -40.45% | -36.35% | -34.68% | -33.80% |
|
|
|||||